Mylan Taiwan Ltd_台灣邁蘭有限公司

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 145 countries and territories. Our workforce of more than 30,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. 美國Mylan是一家全球性製藥公司，致力於建立醫療保健的新標準，以提 供全球70億人高品質的藥品。Mylan不斷創新，以全力滿足不同的需求， 進而藉由全球領導地位影響未來。Mylan可提供約1400種以上的藥品，包 括特殊注射劑型如EpiPen® Auto-Injector（艾筆自動注射筆針），經皮貼 劑，愛滋病的抗逆轉錄病毒（ARV）藥品，以及常用之學名藥品。在發展 中國家大約40％患者依賴著Mylan的抗愛滋病藥物。Mylan企業總部位於 美國賓州匹茲堡市，為美國上市公司（NASDAQ:MYL），全球員工超 過30,000人，銷售據點橫跨145個區域與國家。擁有卓越的研發能力，並 為全球最大的原料藥生產企業之一。無論在何地生產，Mylan皆以全球一 致的品質標準提供給每位需要的患者。